Drazidox

This classification denotes an antibiotic with the molecular formula C10H10N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W193003XW5, chemically known as 3-methyl-2-quinoxalinecarboxylic acid hydrazide 1,4-dioxide. but more generally known as drazidox, which bears US NIH Compound Identifier 208897. European Medicines Agency schedules Drazidox in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06398MIG. The term DRAZIDOX is an International Non-Proprietary Name. DRAZIDOX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CC1=C(N(C2=CC=CC=C2N1O)O)C(=O)N=N.